Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sensitivity, Specificity, and Predicted Value01:13

Sensitivity, Specificity, and Predicted Value

1.7K
In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
1.7K
Preclinical Development: Overview01:28

Preclinical Development: Overview

6.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

UK Groups Plan Cancer Research Hub.

Cancer discovery·2016
Same author

NCI-MATCH Trial Draws Strong Interest.

Cancer discovery·2016
Same author

Expanding the Scope of ENCODE.

Cancer discovery·2016
Same author

CRUK Launches "Grand Challenges".

Cancer discovery·2015
Same author

Is PD-L1 Expression a Biomarker of Response?

Cancer discovery·2015
Same author

Shelved 4-1BB Antibodies Make Comeback.

Cancer discovery·2015
Same journal

Type II JAK2 Inhibitor Gets Off to a Strong Start.

Cancer discovery·2026
Same journal

Pancreatic Cancer: Translating Tumor Biology into Actionability.

Cancer discovery·2026
Same journal

Reconsidering Cancer Therapy through the Lens of Biomolecular Condensates.

Cancer discovery·2026
Same journal

The Promise of Machine Learning-Based Population Screening for Hepatocellular Carcinoma.

Cancer discovery·2026
Same journal

Spatially Resolved Proteomic Cartography Illuminates the Earliest Molecular Programs in Pancreatic Cancer Evolution.

Cancer discovery·2026
Same journal

Oral Regimens for AML Make Strides.

Cancer discovery·2026
See all related articles

Related Experiment Video

Updated: Mar 25, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

8.2K

Illumina Spin-off to Develop Early-Detection Test.

Janet Colwell

    Cancer Discovery
    |February 14, 2016
    PubMed
    Summary
    This summary is machine-generated.

    Illumina launched Grail to develop early cancer detection using liquid biopsies. This new company aims for a low-cost, multi-cancer screening test by 2019.

    More Related Videos

    Design to Implementation Study for Development and Patient Validation of Paper-Based Toehold Switch Diagnostics
    10:42

    Design to Implementation Study for Development and Patient Validation of Paper-Based Toehold Switch Diagnostics

    Published on: June 17, 2022

    3.6K
    Dry Film Photoresist-based Electrochemical Microfluidic Biosensor Platform: Device Fabrication, On-chip Assay Preparation, and System Operation
    13:42

    Dry Film Photoresist-based Electrochemical Microfluidic Biosensor Platform: Device Fabrication, On-chip Assay Preparation, and System Operation

    Published on: September 19, 2017

    12.6K

    Related Experiment Videos

    Last Updated: Mar 25, 2026

    A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
    12:18

    A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

    Published on: January 11, 2020

    8.2K
    Design to Implementation Study for Development and Patient Validation of Paper-Based Toehold Switch Diagnostics
    10:42

    Design to Implementation Study for Development and Patient Validation of Paper-Based Toehold Switch Diagnostics

    Published on: June 17, 2022

    3.6K
    Dry Film Photoresist-based Electrochemical Microfluidic Biosensor Platform: Device Fabrication, On-chip Assay Preparation, and System Operation
    13:42

    Dry Film Photoresist-based Electrochemical Microfluidic Biosensor Platform: Device Fabrication, On-chip Assay Preparation, and System Operation

    Published on: September 19, 2017

    12.6K

    Area of Science:

    • Biotechnology
    • Oncology
    • Genomics

    Background:

    • Illumina, a leader in DNA sequencing, has established Grail, a new venture focused on early cancer detection.
    • Grail is developing innovative liquid biopsy technology for non-invasive cancer screening.

    Discussion:

    • The primary goal is to create a "pan-cancer" test capable of identifying multiple cancer types before clinical symptoms manifest.
    • This approach aims to significantly improve patient outcomes through earlier diagnosis and intervention.

    Key Insights:

    • Liquid biopsies offer a promising avenue for early cancer detection by analyzing cell-free DNA in blood.
    • The development of a low-cost, comprehensive cancer screening test is a key objective.

    Outlook:

    • Grail anticipates introducing its early cancer detection test by 2019.
    • This initiative has the potential to revolutionize cancer diagnostics and patient care.